Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BLOOM
NCT06704594Phase 4Recruiting
- Sponsor
- Johns Hopkins University
- Start
- May 2025
- Primary completion
- Jul 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sertraline in Premenstrual Dysphoric Disorder (PMDD), sponsored by Johns Hopkins University. Started May 2025; status: recruiting.
02
Drugs
sertraline
03
Conditions
Premenstrual Dysphoric Disorder (PMDD)
Beyond the preview
Go deeper on NCT06704594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06704594.